World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Molecular Biology 64 1740 1562 873 770 178 14838

Ruth Lupu publications per year

The chart shows the history of publications by Ruth Lupu between 1980 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Ruth Lupu published across 47 years, from 1980 to 2026, averaging 4.7 papers a year. Output peaked at 23 publications in 2005. 5 of the 221 publications appeared in the last two years.

No. of publications
5 10 15 20
Bar chart. Horizontal axis: year, 1980 to 2026. Vertical axis: number of publications, 0 to 23. Peak 23 publications in 2005. 1980: 1 publication 1981: 0 publications 1982: 0 publications 1983: 0 publications 1984: 0 publications 1985: 0 publications 1986: 0 publications 1987: 1 publication 1988: 1 publication 1989: 1 publication 1990: 2 publications 1991: 2 publications 1992: 8 publications 1993: 9 publications 1994: 3 publications 1995: 4 publications 1996: 5 publications 1997: 2 publications 1998: 2 publications 1999: 4 publications 2000: 4 publications 2001: 5 publications 2002: 5 publications 2003: 7 publications 2004: 13 publications 2005: 23 publications 2006: 16 publications 2007: 10 publications 2008: 8 publications 2009: 9 publications 2010: 2 publications 2011: 2 publications 2012: 6 publications 2013: 5 publications 2014: 5 publications 2015: 4 publications 2016: 5 publications 2017: 6 publications 2018: 3 publications 2019: 4 publications 2020: 5 publications 2021: 4 publications 2022: 3 publications 2023: 15 publications 2024: 2 publications 2025: 4 publications 2026: 1 publication
1980 2026

221 publications in total across all disciplines

View publications per year as a table
Ruth Lupu: publications per year, 1980 to 2026
Year Publications
1980 1
1981 0
1982 0
1983 0
1984 0
1985 0
1986 0
1987 1
1988 1
1989 1
1990 2
1991 2
1992 8
1993 9
1994 3
1995 4
1996 5
1997 2
1998 2
1999 4
2000 4
2001 5
2002 5
2003 7
2004 13
2005 23
2006 16
2007 10
2008 8
2009 9
2010 2
2011 2
2012 6
2013 5
2014 5
2015 4
2016 5
2017 6
2018 3
2019 4
2020 5
2021 4
2022 3
2023 15
2024 2
2025 4
2026 1
Total 221
Download as CSV

Ruth Lupu publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Ruth Lupu sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 53 bars. Horizontal axis: publications, 47–56 to 564+. Vertical axis: number of scientists, 0 to 177. Most scientists, 177, have 117–126 publications. The last bar groups every scientist with 564 publications or more. The highlighted bar, 177–186 publications, is where this scientist sits. 47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47–56 publications 564+

This scientist: 178 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

View publications distribution as a table
Number of Molecular Biology scientists by publication count, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
Publications Scientists This scientist
47–56 7
57–66 17
67–76 65
77–86 90
87–96 125
97–106 131
107–116 162
117–126 177
127–136 158
137–146 158
147–156 146
157–166 159
167–176 131
177–186 110 178
187–196 112
197–206 100
207–216 89
217–226 98
227–236 74
237–246 72
247–256 63
257–266 53
267–276 54
277–286 49
287–296 52
297–306 43
307–316 46
317–326 41
327–336 42
337–346 31
347–356 28
357–366 29
367–376 26
377–386 24
387–396 24
397–406 14
407–416 13
417–426 20
427–436 12
437–446 20
447–456 11
457–466 10
467–476 14
477–486 14
487–496 10
497–506 13
507–516 13
517–526 2
527–536 4
537–546 6
547–556 8
557–563 6
564+ 100
Download as CSV

Ruth Lupu D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Ruth Lupu sits on this spectrum.

No. of scientists
25 50 75 100 125
Bar chart with 54 bars. Horizontal axis: D-Index, 40–41 to 145+. Vertical axis: number of scientists, 0 to 131. Most scientists, 131, have 64–65 D-Index. The last bar groups every scientist with 145 D-Index or more. The highlighted bar, 64–65 D-Index, is where this scientist sits. 40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40–41 D-Index 145+

This scientist: 64 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

View D-Index distribution as a table
Number of Molecular Biology scientists by D-index, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
D-Index Scientists This scientist
40–41 36
42–43 101
44–45 115
46–47 121
48–49 118
50–51 130
52–53 106
54–55 116
56–57 113
58–59 129
60–61 120
62–63 105
64–65 131 64
66–67 95
68–69 97
70–71 106
72–73 83
74–75 89
76–77 77
78–79 70
80–81 73
82–83 60
84–85 48
86–87 45
88–89 50
90–91 31
92–93 51
94–95 43
96–97 38
98–99 39
100–101 41
102–103 29
104–105 33
106–107 35
108–109 20
110–111 38
112–113 19
114–115 28
116–117 13
118–119 23
120–121 16
122–123 15
124–125 11
126–127 21
128–129 7
130–131 13
132–133 14
134–135 17
136–137 9
138–139 8
140–141 16
142–143 7
144 7
145+ 100
Download as CSV

Overview

Ruth Lupu is affiliated with the Mayo Clinic in the United States, where they contribute to research primarily in the fields of Biochemistry, Genetics and Molecular Biology, and Medicine. Their scientific work is concentrated on cancer biology, with a strong focus on cancer research and molecular biology. Oncology, pulmonary and respiratory medicine, and pharmacology also form part of their research scope.

The main topics addressed in Ruth Lupu's work include:

  • Cancer, Lipids, and Metabolism
  • Cancer, Hypoxia, and Metabolism
  • Peroxisome Proliferator-Activated Receptors
  • Lung Cancer Treatments and Mutations
  • Cancer Immunotherapy and Biomarkers
  • RNA modifications and cancer
  • HER2/EGFR in Cancer Research

Ruth Lupu has co-authored numerous papers with several frequently collaborating researchers, notably:

  • Javier A. Menéndez (16 publications)
  • Elisabet Cuyàs (15 publications)
  • Sara Verdura (15 publications)
  • Travis Vander Steen (9 publications)
  • Begoña Martı́n-Castillo (6 publications)

Their research is regularly published in journals such as:

  • Cancers (3 publications)
  • Annals of Oncology (3 publications)
  • Cell Death Discovery (2 publications)
  • Expert Opinion on Therapeutic Targets (2 publications)
  • International Journal of Molecular Sciences (2 publications)

Some of Ruth Lupu's recent papers include:

  • Fatty acid synthase (FASN) regulates the mitochondrial priming of cancer cells, 2021, Cell Death and Disease
  • Fatty Acid Synthase Confers Tamoxifen Resistance to ER+/HER2+ Breast Cancer, 2021, Cancers
  • Fatty acid synthase: a druggable driver of breast cancer brain metastasis, 2022, Expert Opinion on Therapeutic Targets
  • Fatty Acid Synthase Is a Key Enabler for Endocrine Resistance in Heregulin-Overexpressing Luminal B-Like Breast Cancer, 2020, International Journal of Molecular Sciences
  • Tumor Cell-Intrinsic Immunometabolism and Precision Nutrition in Cancer Immunotherapy, 2020, Cancers

Best Publications

  • Reciprocal interactions between β1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: A different perspective in epithelial biology

    Fei Wang;Valerie M. Weaver;Ole W. Petersen;Carolyn A. Larabell

  • Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2.

    Ruth Lupu;Ramon Colomer;Gerhard Zugmaier;Jay Sarup

  • Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin™) in breast cancer cells with Her-2/neu oncogene amplification

    J. A. Menendez;L. Vellon;R. Colomer;R. Lupu;R. Lupu

  • Expression and regulation of estrogen receptor beta in human breast tumors and cell lines.

    Unknown

  • Expression of Estrogen Receptor β Messenger RNA Variant in Breast Cancer

    Unknown

  • Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells.

    A. Vazquez-Martin;R. Colomer;J. Brunet;R. Lupu

  • Pharmacological inhibitors of Fatty Acid Synthase (FASN)--catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents?

    Ruth Lupu;Javier A Menendez;Javier A Menendez

  • Antibody‐induced growth inhibition is mediated through immunochemically and functionally distinct epitopes on the extracellular domain of the c‐erbb‐2 (her‐2/neu) gene product p185

    Fengji Xu;Ruth Lupu;Gustavo C. Rodriguez;Regina S. Whitaker

  • Involvement of Heregulin-β2 in the Acquisition of the Hormone-independent Phenotype of Breast Cancer Cells

    Unknown

  • Transforming Growth Factor β1 Induces Cachexia and Systemic Fibrosis without an Antitumor Effect in Nude Mice

    Gerhard Zugmaier;Soonmyoung Paik;George Wilding;Cornelius Knabbe

  • A genomic explanation connecting “Mediterranean diet”, olive oil and cancer: Oleic acid, the main monounsaturated Fatty acid of olive oil, induces formation of inhibitory “PEA3 transcription factor-PEA3 DNA binding site” complexes at the Her-2/neu (erbB-2) oncogene promoter in breast, ovarian and stomach cancer cells

    Javier A. Menendez;Adriana Papadimitropoulou;Adriana Papadimitropoulou;Luciano Vellon;Luciano Vellon;Ruth Lupu;Ruth Lupu

  • Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.

    Javier A. Menendez;Luciano Vellon;Luciano Vellon;Ramon Colomer;Ruth Lupu;Ruth Lupu

  • The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives.

    J A Menéndez;I Mehmi;D W Griggs;R Lupu

  • Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses

    Ruth Lupu;Ramon Colomer;Bhanu Kannan;Marc E. Lippman

  • Neu Differentiation Factor (Heregulin) Induces Expression of Intercellular Adhesion Molecule 1: Implications for Mammary Tumors

    Sarah S. Bacus;Andrei V. Gudkov;Carolyn R. Zelnick;Dot Chin

  • erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification.

    R. Colomer;R. Lupu;S. S. Bacus;E. P. Gelmann

  • A ligand for the erbB-2 oncogene product (gp30) induces differentiation of human breast cancer cells

    Sarah S. Bacus;Eliezer Huberman;Dot Chin;Kaoru Kiguchi

  • Mediterranean dietary traditions for the molecular treatment of human cancer: anti-oncogenic actions of the main olive oil's monounsaturated fatty acid oleic acid (18:1n-9)

    Javier A Menendez;Ruth Lupu

  • Increased miR-708 Expression in NSCLC and Its Association with Poor Survival in Lung Adenocarcinoma from Never Smokers

    Jin Sung Jang;Hyo Sung Jeon;Zhifu Sun;Marie Christine Aubry

  • Oncogenic properties of the endogenous fatty acid metabolism: molecular pathology of fatty acid synthase in cancer cells.

    Javier A Menendez;Ruth Lupu

Frequent Co-Authors

Javier A. Menendez
Javier A. Menendez Catalan Institute of Oncology
Judith Campisi
Judith Campisi Buck Institute for Research on Aging
Erik W. Thompson
Erik W. Thompson Queensland University of Technology
George Kemble
George Kemble Sagimet Biosciences
María J. Vicent
María J. Vicent Cardiff University
Jorge Joven
Jorge Joven Rovira i Virgili University
Edward B. Leof
Edward B. Leof Mayo Clinic
Marvin C. Gershengorn
Marvin C. Gershengorn National Institutes of Health
Vicente Micol
Vicente Micol Miguel Hernandez University
Walter Berger
Walter Berger Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in Molecular Biology, there are several related online degrees and pathways in the healthcare and biosciences fields. Many students explore different routes to advance their qualifications or shift to specialized roles.

For those interested in clinical applications or direct patient care, understanding how long does it take to become a nurse practitioner can help you plan your education timeline. Alternatively, registered nurses aiming to advance can find accelerated options like the rn to bsn online programs, which offer degree completion in as little as six months.

Those with an associate degree in nursing can leverage specialized bridge programs, including adn to np pathways, to fast-track their graduate studies and maximize career flexibility. For non-nurses considering a rapid transition into advanced practice, direct entry msn programs for non-nurses online allow candidates from diverse scientific backgrounds—such as Molecular Biology—to enter the nursing field efficiently.

Exploring these related online degrees can open doors to diverse and rewarding careers in healthcare and research.

Best Scientists Citing Ruth Lupu

Trending Scientists

Recently Published Articles